The vaccine is being jointly developed by German biotech firm BioNTech and U.S.-based Pfizer.
In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.to produce and deliver 100 million doses of its COVID-19 vaccine candidate in the U.S. if it proves safe and effective in humans, the government announced Wednesday.
Under the agreement, the U.S. can acquire an additional 500 million doses, the Department of Health and Human Services added. The vaccine is being jointly developed by German biotech firm"Through Operation Warp Speed, we are assembling a portfolio of vaccines to increase the odds that the American people will have at least one safe, effective vaccine as soon as the end of this year," HHS Secretary Alex Azar said in a statement.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Britain Secures 90 Million Doses Of Potential Coronavirus Vaccines From Pfizer, BioNTech & ValnevaAn effective vaccine is yet to be proven, however the U.K. has now secured access to up to 230 million vaccine doses.
続きを読む »
Pfizer-BioNTech potential COVID-19 vaccine shows promise in additional dataGerman biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.
続きを読む »
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, ValnevaBritain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech , and French group Valneva , the business ministry said on Monday.
続きを読む »
Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trialGerman biotech BioNTech and U.S. drugmaker Pfizer Inc on Monday said data from an early-stage trial of their experimental coronavirus vaccine showed that it prompted an immune response and was well-tolerated, similar to results seen in prior early test.
続きを読む »
Britain Secures 90 Million Doses Of Potential Coronavirus Vaccines From Pfizer, BioNTech & ValnevaAn effective vaccine is yet to be proven, however the U.K. has now secured access to up to 230 million vaccine doses.
続きを読む »